Dual-functional c(RGDyK)-decorated Pluronic micelles designed for antiangiogenesis and the treatment of drug-resistant tumor

References

• ZhangBZhangYLiaoZUPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain gliomaBiomaterials2015369810925443789
   PubMed Web of Science ®Google Scholar
• OngBYSRanganathSHLeeLYPaclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiformeBiomaterials200930183189319619285718
   PubMed Web of Science ®Google Scholar
• LammersTHenninkWEStormGTumour-targeted nanomedicines: principles and practiceBr J Cancer200899339239718648371
   PubMed Web of Science ®Google Scholar
• GuoXShiCYangGWangJCaiZZhouSDual-responsive polymer micelles for target-cell-specific anticancer drug deliveryChem Mater2014261544054418
   Web of Science ®Google Scholar
• FolkmanJWhat is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst1990821471688381
   PubMed Web of Science ®Google Scholar
• BergersGBenjaminLETumorigenesis and the angiogenic switchNat Rev Cancer20033640141012778130
   PubMed Web of Science ®Google Scholar
• FolkmanJTumor angiogenesis: therapeutic implicationsN Engl J Med1971285118211864938153
   PubMed Web of Science ®Google Scholar
• CarmelietPJainRKAngiogenesis in cancer and other diseasesNature2000407680124925711001068
   PubMed Web of Science ®Google Scholar
• CoxDBrennanMMoranNIntegrins as therapeutic targets: lessons and opportunitiesNat Rev Drug Discov201091080482020885411
   PubMed Web of Science ®Google Scholar
• ReynoldsLEWyderLLivelyJCEnhanced pathological angio-genesis in mice lacking β3 integrin or β3 and β5 integrinsNat Med200281273411786903
   PubMed Web of Science ®Google Scholar
• EliceiriBPChereshDAThe role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical developmentJ Clin Invest19991039122710225964
   PubMed Web of Science ®Google Scholar
• AdulnirathAChungSWParkJCyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitorJ Control Release2012164181623063549
   PubMedGoogle Scholar
• DeSRazorenovaOMcCabeNPO’TooleTQinJByzovaTVVEGF–integrin interplay controls tumor growth and vascularizationProc Natl Acad Sci U S A2005102217589759415897451
   PubMed Web of Science ®Google Scholar
• WangZChuiW-KHoPCIntegrin targeted drug and gene deliveryExpert Opin Drug Deliv20107215917120095940
   PubMed Web of Science ®Google Scholar
• Eldar-BoockAMillerKSanchisJLupuRVicentMJSatchi-FainaroRIntegrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxelBiomaterials201132153862387421376390
   PubMed Web of Science ®Google Scholar
• ConnellyJTGarcíaAJLevenstonMEInhibition of in vitro chondro-genesis in RGD-modified three-dimensional alginate gelsBiomaterials20072861071108317123602
   PubMedGoogle Scholar
• GaoYChenLZhangZChenYLiYReversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticlesBiomaterials20113261738174721112086
   PubMed Web of Science ®Google Scholar
• TakahashiSItoYHatakeKSugimotoYGene therapy for breast cancer – review of clinical gene therapy trials for breast cancer and mdr1 gene therapy trial in cancer institute hospitalBreast Cancer200613181516518057
   PubMedGoogle Scholar
• ClarkeRLeonessaFTrockBMultidrug resistance/p-glycoprotein and breast cancer: review and meta-analysisSemin Oncol2005326 Suppl 7S9S1516360717
   PubMed Web of Science ®Google Scholar
• MamotCDrummondDCHongKKirpotinDBParkJWLiposome-based approaches to overcome anticancer drug resistanceDrug Resist Updat20036527127914643297
   PubMed Web of Science ®Google Scholar
• KabanovAVBatrakovaEVAlakhovVYPluronic® block copolymers for overcoming drug resistance in cancerAdv Drug Deliv Rev200254575977912204601
   PubMed Web of Science ®Google Scholar
• LeeESNaKBaeYHDoxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJ Control Release2005103240541815763623
   PubMed Web of Science ®Google Scholar
• WangYYuLHanLShaXFangXDifunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell linesInt J Pharm20073371–2637317289311
   PubMed Web of Science ®Google Scholar
• WangYLiYZhangLFangXPharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105 polymeric micellesArch Pharm Res200831453053818449513
   PubMed Web of Science ®Google Scholar
• WangYHaoJLiYPoly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumorsBiomaterials201233184741475122445254
   PubMed Web of Science ®Google Scholar
• ChenLShaXJiangXChenYRenQFangXPluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluationInt J Nanomedicine201387323319859
   PubMed Web of Science ®Google Scholar
• ChenYZhangWGuJEnhanced antitumor efficacy by metho-trexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancerInt J Pharm20134521–242143323688623
   PubMed Web of Science ®Google Scholar
• ZhangWShiYChenYYeJShaXFangXMultifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumorsBiomaterials201132112894290621256584
   PubMed Web of Science ®Google Scholar
• ZhouQZhangZChenTGuoXZhouSPreparation and characterization of thermosensitive pluronic F127-b-poly(ε-caprolactone) mixed micellesColloids Surf B: Biointerfaces2011861455721489759
   PubMedGoogle Scholar
• AhmedFPakunluRIBrannanABatesFMinkoTDischerDEBiodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drugJ Control Release2006116215015816942814
   PubMed Web of Science ®Google Scholar
• GustafsonDLMerzALLongMEPharmacokinetics of combined doxorubicin and paclitaxel in miceCancer Lett2005220216116915766591
   PubMed Web of Science ®Google Scholar
• ChenYShaXZhangWPluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluationInt J Nanomedicine20138146323620663
   PubMed Web of Science ®Google Scholar
• ZhangWShiYChenYEnhanced antitumor efficacy by Paclitaxel-loaded Pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistanceEur J Pharm Biopharm201075334135320451605
   PubMed Web of Science ®Google Scholar
• GaoHYangZZhangSPangZLiuQJiangXStudy and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assaysActa Biomater201410285886724239900
   PubMedGoogle Scholar
• LiuCLiuFFengLLiMZhangJZhangNThe targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticlesBiomaterials201334102547256423332321
   PubMed Web of Science ®Google Scholar
• QiuLBaeYPolymer Architecture and Drug DeliveryPharm Res200623113016392022
   PubMed Web of Science ®Google Scholar
• WangHZhaoYWuYEnhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticlesBiomaterials201132328281829021807411
   PubMed Web of Science ®Google Scholar
• RapoportNPittWGSunHNelsonJLDrug delivery in polymeric micelles: from in vitro to in vivoJ Control Release2003911–2859512932640
   PubMed Web of Science ®Google Scholar
• PolisenoLTuccoliAMarianiLMicroRNAs modulate the angiogenic properties of HUVECsBlood200610893068307116849646
   PubMedGoogle Scholar
• MatsuiJWakabayashiTAsadaMYoshimatsuKOkadaMStem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cellsJ Biol Chem200427918186001860714985355
   PubMed Web of Science ®Google Scholar
• BatrakovaEVKabanovAVPluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiersJ Control Release200813029810618534704
   PubMed Web of Science ®Google Scholar
• DesgrosellierJSChereshDAIntegrins in cancer: biological implications and therapeutic opportunitiesNat Rev Cancer201010192220029421
   PubMed Web of Science ®Google Scholar
• LeeSKimJShimGTetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptorJ Control Release2012164221322022664473
   PubMedGoogle Scholar
• AbuHammadSZihlifMGene expression alterations in doxorubi-cin resistant MCF7 breast cancer cell lineGenomics2013101421322023201559
   PubMedGoogle Scholar
• de HoonJPJVeeckJVriensBEPJCalonTGAvan EngelandMTjan-HeijnenVCGTaxane resistance in breast cancer: a closed HER2 circuit?Biochim Biophys Acta20121825219720622280939
   PubMedGoogle Scholar
• MinchintonAITannockIFDrug penetration in solid tumoursNat Rev Cancer20066858359216862189
   PubMed Web of Science ®Google Scholar
• DhanikulaRSArgawABouchardJ-FHildgenPMethotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capabilityMol Pharm20085110511618171013
   PubMedGoogle Scholar
• DaviesCMüllerHHagenIGårsethMHjelstuenMComparison of extracellular matrix in human osteosarcomas and melanomas growing as xenografts, multicellular spheroids, and monolayer culturesAnticancer Res1996176D431743269494527
   PubMedGoogle Scholar
• JiangXShaXXinHIntegrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxelBiomaterials201334122969297923380351
   PubMedGoogle Scholar
• SchechnerJSNathAKZhengLIn vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouseProc Natl Acad Sci U S A200097169191919610890921
   PubMedGoogle Scholar